A case report: Response to Osimertinib in non-small cell lung cancer patient with uncommon EGFR mutation Article (Web of Science)

cited authors

  • Craig, Daniel J.; Kahlon, Navkirat K.; Hamouda, Danae M.

publication date

  • December 1, 2022

webpage

published in

category

keywords

  • EGFR
  • Non -small cell lung cancer
  • Osimertinib
  • Tyrosine kinase inhibitors

volume

  • 8